Brie Carter

White Cliff Minerals (ASX:WCN) has reported encouraging results from its deep drilling program at the Danvers Copper deposit.

Servcorp (ASX:SRV) has upgraded its 2026 financial year guidance, citing continued operational momentum, improved revenue efficiency and strong cash generation across its global portfolio.

Coast Entertainment (ASX:CEH) has provided a preliminary update on its unaudited trading performance for the half year ended Dec. 30, 2025, reflecting 27 weeks of trading in FY26, a 53-week year.

Lynas Rare Earths (ASX:LYC) reported a 30% drop in neodymium-praseodymium output to 1,404 tonnes for the quarter.

Energy Fuels has agreed to acquire Australian Strategic Materials (ASX:ASM) in a transaction that aims to create a near-term, Western-focused "mine to metal and alloy" rare earths champion.

MAIA-BIOTECH-2026-CLINICAL-OUTLOOK

Corporación América Airports (NYSE:CAAP) reported robust passenger growth for 2025, fueled by a surge in international travel and record-breaking performances in key markets.

Eli Lilly (NYSE:LLY) shares gained after the U.S. Food and Drug Administration granted Breakthrough Therapy designation to its experimental antibody-drug conjugate, potentially accelerating the path to market for a treatment targeting hard-to-treat gynecologic cancers.

Netflix (NYSE:WBD) and Warner Bros. Discovery (NYSE:WBD) amended their definitive merger agreement on Tuesday, pivoting to an all-cash transaction to provide shareholders with greater price protection and accelerate the closing timeline.

Moderna (NASDAQ:MRNA) and Merck (NYSE:MRK) announced Tuesday that their individualized neoantigen therapy continues to show dramatic long-term benefits, providing the strongest evidence to date that mRNA technology can be harnessed to treat established cancer.